Home Tags Sanofi

Tag: Sanofi

Boehringer Ingelheim, Sanofi targeted in class-action suit over Zantac

According to the lawsuit, “Zantac’s unprecedented sales were possible only because of a deception perpetrated by the drug’s manufacturers on consumers.”

Federal court rules in favor of Regeneron in Praluent patent lawsuit

Judge Richard Andrews’ Aug. 28 ruling overturned portions of a jury verdict in February that found Amgen’s patents on its cholesterol drug Repatha were valid. Regeneron and Sanofi sell rival drug Praluent.

Regeneron moves closer to European approval of drug for asthma

In the U.S., it is indicated for use by prescription to treat moderate-to-severe atopic dermatitis, also known as eczema.

FDA approves Regeneron, Sanofi skin cancer immuno-oncology drug

The drug is the first FDA-approved treatment for patients with advanced forms of a skin cancer known as cutaneous squamous cell carcinoma. 

FDA to review Regeneron’s cemiplimab for treatment of squamous cell carcinoma

These cancers commonly appear on sun-exposed areas of the body such as the face, ears, neck, lips and backs of the hands.

European agency to review Regeneron-Sanofi drug applications

The European agency will also review the marketing authorization application for cemiplimab, which is used to treat patients with metastatic cutaneous squamous cell carcinoma.

Regeneron dermatitis drug Dupixent approved in Japan

The antibody drug was approved for use in the U,S. last March.

Regeneron, Sanofi increase investment in drug developments

The companies will increase their investments in the development of cancer drug cemiplimab and food allergy drug dupilumab.

Regeneron, Sanofi announce positive results for food allergy drug

Dupilumab showed positive results in adults with eosinophilic esophagitis, an allergic inflammatory disease that damages the esophagus.

Regeneron dermatitis drug approved for European market

The antibody drug will be marketed as Dupixent and available to adults with moderate to severe atopic dermatitis .

Regeneron drug for rheumatoid arthritis approved in Europe

The European Commission approved the use of Kevzara under certain conditions to treat adults with moderately to severely active rheumatoid arthritis.

FDA approves Regeneron drug Kevzara for rheumatoid arthritis

The new human antibody drug will be used to treat a chronic inflammatory disease that affects about 1.3 million Americans.

FDA approves new Regeneron drug treating severe eczema

Dupixent will go on the U.S. market this week as the first antibody medicine for uncontrolled itching and rashes in adults with atopic dermatitis.

Boehringer ridding itself of U.S. consumer health products; Ridgefield impact to...

Under the proposed swap, Boehringer will acquire Sanofi’s animal care subsidiary, while Sanofi will obtain Boehringer’s consumer health care business unit.

MannKind regains marketing rights to inhaled insulin

The drug went on sale in early 2015, but original and current marketer Sanofi had difficulty in marketing it effectively.